Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder

Archive ouverte

Courraud, Jérémie | Chater-Diehl, Eric | Durand, Benjamin | Vincent, Marie | del Mar Muñiz Moreno, Maria | Boujelbene, Imène | Drouot, Nathalie | Genschik, Lauréline | Schaefer, Elise | Nizon, Mathilde | Gerard, Bénédicte | Abramowicz, Marc | Cogné, Benjamin | Bronicki, Lucas | Burglen, Lydie | Barth, Magalie | Charles, Perrine | Colin, Estelle | Coubes, Christine | David, Albert | Delobel, Bruno | Demurger, Florence | Passemard, Sandrine | Denommé-Pichon, Anne-Sophie | Faivre, Laurence | Feger, Claire | Fradin, Mélanie | Francannet, Christine | Genevieve, David | Goldenberg, Alice | Guerrot, Anne-Marie | Isidor, Bertrand | Johannesen, Katrine M. | Keren, Boris | Kibæk, Maria | Kuentz, Paul | Mathieu-Dramard, Michele | Demeer, Bénédicte | Metreau, Julia | Møller, Rikke Steensbjerre | Moutton, Sébastien | Pasquier, Laurent | Pilekær Sørensen, Kristina | Perrin, Laurence | Renaud, Mathilde | Saugier, Pascale | Rio, Marlène | Svane, Joane | Thevenon, Julien | Tran Mau-Them, Frédéric | Tronhjem, Cathrine Elisabeth | Vitobello, Antonio | Layet, Valerie | Auvin, Stéphane | Khachnaoui, Khaoula | Birling, Marie-Christine | Drunat, Séverine | Bayat, Allan | Dubourg, Christèle | El Chehadeh, Salima | Fagerberg, Christina | Mignot, Cyril | Guipponi, Michel | Bienvenu, Thierry | Herault, Yann | Thompson, Julie | Willems, Marjolaine | Mandel, Jean-Louis | Weksberg, Rosanna | Piton, Amelie

Edité par CCSD ; Nature Publishing Group -

Purpose: DYRK1A syndrome is among the most frequent monogenic forms of intellectual disability (ID). We refined the molecular and clinical description of this disorder and developed tools to improve interpretation of missense variants, which remains a major challenge in human genetics.Methods: We reported clinical and molecular data for 50 individuals with ID harboring DYRK1A variants and developed (1) a specific DYRK1A clinical score; (2) amino acid conservation data generated from 100 DYRK1A sequences across different taxa; (3) in vitro overexpression assays to study level, cellular localization, and kinase activity of DYRK1A mutant proteins; and (4) a specific blood DNA methylation signature.Results: This integrative approach was successful to reclassify several variants as pathogenic. However, we questioned the involvement of some others, such as p.Thr588Asn, still reported as likely pathogenic, and showed it does not cause an obvious phenotype in mice.Conclusion: Our study demonstrated the need for caution when interpreting variants in DYRK1A, even those occurring de novo. The tools developed will be useful to interpret accurately the variants identified in the future in this gene.

Suggestions

Du même auteur

PFMG2025–integrating genomic medicine into the national healthcare system in France

Archive ouverte | Abadie, Caroline | CCSD

International audience. Integrating genomic medicine into healthcare systems is a health policy challenge that requires continuously transferring scientific advances into clinics and ensuring equal access for patien...

Episignatures in practice: independent evaluation of published episignatures for the molecular diagnostics of ten neurodevelopmental disorders

Archive ouverte | Husson, Thomas | CCSD

International audience. Variants of uncertain significance (VUS) are a significant issue for the molecular diagnosis of rare diseases. The publication of episignatures as effective biomarkers of certain Mendelian ne...

Growth charts in DYRK1A syndrome

Archive ouverte | Lanvin, Pierre‐louis | CCSD

International audience. DYRK1A Syndrome (OMIM #614104) is caused by pathogenic variations in the DYRK1A gene located on 21q22. Haploinsufficiency of DYRK1A causes a syndrome with global psychomotor delay and intelle...

Chargement des enrichissements...